Key findings
- Mounjaro is #1 worldwide. It takes 47% of all GLP-1 brand searches we measured, ahead of Ozempic (28%), Wegovy (15%), Zepbound (8%) and Saxenda (2%).
- But Ozempic still leads in more countries: 50 countries against 36 for Mounjaro. Mounjaro wins the biggest markets: it leads in 7 of the 10 countries with the most GLP-1 searches.
- Brazil is the world's #2 GLP-1 search market. Brazilians search Mounjaro about 1,830,110 times a month, 79% of all brand searches there. That is more than twice the Mounjaro searches in the US.
- Japan is a Mounjaro country. "マンジャロ" alone gets about 450,000 searches a month, and Mounjaro takes 83% of GLP-1 brand searches in Japan.
- The US is the closest race. Mounjaro (826,700) and Zepbound (823,380), both tirzepatide, are almost tied, with Ozempic (675,600) and Wegovy (551,780) close behind.
- Tirzepatide brands beat semaglutide brands. Mounjaro and Zepbound together get about 6,993,200 searches a month; Ozempic and Wegovy about 5,476,860.
- Wegovy leads in 4 countries: Switzerland, Denmark, Norway, New Zealand.
The top GLP-1 brand in every country
Average monthly Google searches per brand, sorted by total GLP-1 brand searches. The share is the leading brand's part of all five brands.
| Country | Top brand | Share | Mounjaro | Ozempic | Wegovy | Zepbound | Saxenda |
|---|---|---|---|---|---|---|---|
| United States | Mounjaro | 28% | 826,700 | 675,600 | 551,780 | 823,380 | 33,230 |
| Brazil | Mounjaro | 79% | 1,830,110 | 246,080 | 201,050 | 8,120 | 33,140 |
| United Kingdom | Mounjaro | 63% | 451,000 | 111,040 | 135,170 | 9,940 | 5,470 |
| Mexico | Mounjaro | 43% | 301,130 | 246,080 | 135,070 | 8,130 | 18,130 |
| Japan | Mounjaro | 83% | 459,480 | 32,720 | 24,300 | 34,010 | 3,150 |
| Germany | Mounjaro | 44% | 203,690 | 172,340 | 74,330 | 2,940 | 5,610 |
| France | Ozempic | 39% | 135,700 | 135,850 | 74,110 | 1,630 | 4,460 |
| Italy | Mounjaro | 46% | 135,420 | 110,700 | 40,580 | 1,620 | 4,460 |
| Canada | Ozempic | 38% | 75,000 | 110,700 | 60,860 | 40,550 | 5,450 |
| Poland | Ozempic | 48% | 91,680 | 138,260 | 40,610 | 2,930 | 12,270 |
| India | Ozempic | 62% | 74,180 | 165,130 | 18,170 | 6,630 | 2,950 |
| Spain | Ozempic | 43% | 90,910 | 110,840 | 49,570 | 1,930 | 4,470 |
| Türkiye | Mounjaro | 57% | 135,580 | 74,850 | 18,160 | 1,930 | 8,200 |
| Australia | Mounjaro | 50% | 110,730 | 60,690 | 40,740 | 4,440 | 3,650 |
| Colombia | Ozempic | 33% | 60,560 | 60,570 | 33,140 | 1,900 | 27,120 |
| Chile | Ozempic | 55% | 27,150 | 90,550 | 33,130 | 730 | 12,130 |
| Netherlands | Ozempic | 50% | 50,230 | 76,670 | 12,170 | 1,330 | 12,190 |
| Sweden | Mounjaro | 43% | 60,860 | 49,990 | 27,150 | 900 | 2,940 |
| South Korea | Mounjaro | 64% | 79,320 | 5,830 | 35,130 | 1,130 | 2,630 |
| Argentina | Ozempic | 69% | 18,170 | 74,110 | 12,140 | 610 | 2,430 |
| Romania | Mounjaro | 58% | 60,660 | 22,470 | 18,130 | 740 | 2,440 |
| Belgium | Mounjaro | 49% | 49,760 | 27,430 | 22,240 | 740 | 1,630 |
| Portugal | Mounjaro | 63% | 60,600 | 22,430 | 12,140 | 500 | 1,040 |
| Philippines | Mounjaro | 43% | 40,800 | 40,570 | 6,700 | 4,430 | 1,930 |
| Ukraine | Ozempic | 58% | 22,040 | 47,350 | 2,510 | 1,150 | 8,380 |
| Malaysia | Mounjaro | 59% | 40,760 | 18,190 | 8,180 | 610 | 1,640 |
| Czechia | Ozempic | 42% | 27,570 | 28,120 | 8,150 | 410 | 2,470 |
| Saudi Arabia | Mounjaro | 51% | 32,190 | 11,810 | 16,220 | 750 | 2,040 |
| South Africa | Ozempic | 54% | 18,170 | 33,150 | 8,130 | 1,020 | 910 |
| Switzerland | Wegovy | 36% | 18,300 | 18,490 | 22,260 | 620 | 1,350 |
| Egypt | Mounjaro | 49% | 26,990 | 11,160 | 13,520 | 740 | 3,150 |
| Peru | Ozempic | 40% | 18,150 | 22,270 | 4,430 | 500 | 9,920 |
| Austria | Ozempic | 42% | 22,460 | 22,770 | 6,640 | 400 | 1,350 |
| Indonesia | Ozempic | 51% | 10,120 | 27,240 | 14,900 | 510 | 430 |
| Hungary | Ozempic | 36% | 18,200 | 18,290 | 9,940 | 400 | 4,440 |
| United Arab Emirates | Mounjaro | 54% | 24,840 | 10,450 | 9,140 | 920 | 650 |
| Denmark | Wegovy | 50% | 8,230 | 12,340 | 22,240 | 610 | 920 |
| Greece | Mounjaro | 46% | 20,160 | 17,520 | 4,450 | 510 | 750 |
| Bulgaria | Ozempic | 55% | 12,630 | 23,460 | 4,830 | 320 | 1,050 |
| Norway | Wegovy | 43% | 10,080 | 12,580 | 18,140 | 410 | 910 |
| Ireland | Mounjaro | 44% | 18,250 | 15,130 | 4,450 | 920 | 2,430 |
| Slovakia | Ozempic | 47% | 14,960 | 18,420 | 4,430 | 190 | 910 |
| Finland | Ozempic | 63% | 6,790 | 22,900 | 3,640 | 340 | 2,950 |
| Thailand | Mounjaro | 52% | 18,680 | 8,540 | 6,710 | 620 | 1,640 |
| Ecuador | Ozempic | 49% | 9,940 | 14,850 | 1,320 | 320 | 3,640 |
| New Zealand | Wegovy | 41% | 8,270 | 8,160 | 12,200 | 610 | 760 |
| Singapore | Ozempic | 43% | 10,250 | 12,200 | 4,500 | 750 | 630 |
| Croatia | Ozempic | 45% | 9,970 | 12,190 | 4,430 | 230 | 490 |
| Serbia | Ozempic | 46% | 6,700 | 12,550 | 6,640 | 180 | 1,030 |
| Kazakhstan | Ozempic | 77% | 5,150 | 20,830 | 670 | 120 | 310 |
| Israel | Mounjaro | 40% | 10,540 | 9,850 | 4,900 | 420 | 930 |
| Venezuela | Ozempic | 49% | 9,940 | 12,160 | 910 | 260 | 1,620 |
| Dominican Republic | Mounjaro | 46% | 9,950 | 8,140 | 1,930 | 720 | 730 |
| Taiwan | Ozempic | 38% | 7,470 | 8,160 | 4,500 | 740 | 520 |
| Hong Kong SAR China | Mounjaro | 44% | 8,500 | 6,760 | 2,980 | 420 | 520 |
| Lithuania | Ozempic | 51% | 4,540 | 8,760 | 3,640 | 160 | 150 |
| Vietnam | Ozempic | 49% | 5,130 | 8,450 | 1,500 | 510 | 1,650 |
| Belarus | Ozempic | 82% | 2,230 | 13,610 | 270 | 190 | 230 |
| Kuwait | Mounjaro | 48% | 6,540 | 1,890 | 4,820 | 190 | 190 |
| Costa Rica | Ozempic | 61% | 2,950 | 8,160 | 1,010 | 260 | 890 |
| Morocco | Ozempic | 51% | 4,780 | 6,720 | 920 | 160 | 620 |
| Uruguay | Ozempic | 63% | 3,650 | 8,140 | 1,030 | 70 | 100 |
| Paraguay | Mounjaro | 46% | 5,450 | 5,440 | 610 | 120 | 270 |
| Algeria | Ozempic | 50% | 4,020 | 5,510 | 1,030 | 90 | 350 |
| Uzbekistan | Ozempic | 60% | 3,890 | 6,440 | 250 | 80 | 160 |
| Guatemala | Ozempic | 65% | 1,940 | 6,660 | 600 | 220 | 890 |
| Lebanon | Mounjaro | 46% | 4,720 | 3,720 | 1,330 | 200 | 290 |
| Iraq | Mounjaro | 44% | 4,350 | 3,850 | 800 | 190 | 800 |
| Azerbaijan | Ozempic | 47% | 3,120 | 4,100 | 950 | 100 | 460 |
| Bosnia & Herzegovina | Ozempic | 54% | 1,950 | 4,440 | 1,630 | 50 | 120 |
| Tunisia | Ozempic | 56% | 2,580 | 4,460 | 620 | 60 | 190 |
| Honduras | Ozempic | 56% | 1,320 | 4,440 | 1,620 | 220 | 260 |
| Georgia | Ozempic | 43% | 3,300 | 3,380 | 650 | 280 | 210 |
| Jordan | Mounjaro | 44% | 3,270 | 2,180 | 1,490 | 180 | 360 |
| Panama | Ozempic | 50% | 2,450 | 3,660 | 740 | 180 | 280 |
| Moldova | Ozempic | 45% | 1,860 | 3,090 | 1,690 | 60 | 110 |
| Qatar | Mounjaro | 51% | 3,430 | 1,700 | 1,350 | 120 | 150 |
| El Salvador | Ozempic | 70% | 1,020 | 4,430 | 600 | 170 | 90 |
| Cyprus | Mounjaro | 46% | 2,580 | 2,240 | 520 | 100 | 140 |
| Bolivia | Ozempic | 55% | 1,940 | 2,940 | 270 | 70 | 110 |
| Armenia | Ozempic | 50% | 2,090 | 2,460 | 200 | 80 | 50 |
| Nicaragua | Ozempic | 70% | 750 | 2,950 | 330 | 110 | 50 |
| Oman | Mounjaro | 52% | 1,760 | 980 | 490 | 70 | 110 |
| Bahrain | Mounjaro | 44% | 1,430 | 820 | 910 | 60 | 60 |
| Kyrgyzstan | Ozempic | 71% | 700 | 2,180 | 80 | 30 | 70 |
| Montenegro | Ozempic | 53% | 530 | 1,410 | 610 | 30 | 60 |
| Mozambique | Mounjaro | 82% | 1,960 | 340 | 50 | 10 | 20 |
| Côte d’Ivoire | Ozempic | 45% | 920 | 1,040 | 280 | 20 | 40 |
| Angola | Mounjaro | 78% | 1,630 | 360 | 70 | 10 | 20 |
| Senegal | Ozempic | 56% | 370 | 770 | 190 | 20 | 20 |
Worldwide totals
| Search | Searches / month (90 countries) | Top brand in |
|---|---|---|
| Mounjaro | 6,010,820 | 36 countries |
| Ozempic | 3,529,250 | 50 countries |
| Wegovy | 1,947,610 | 4 countries |
| Zepbound | 982,380 | – |
| Saxenda | 280,160 | – |
| Tirzepatide (generic name) | 1,897,910 | – |
| Semaglutide (generic name) | 1,269,810 | – |
How we measured it
- Source: Google Ads Keyword Planner, average monthly Google searches over the last 12 months, measured 2026-11-20.
- Brands: Mounjaro, Ozempic, Wegovy, Zepbound and Saxenda, plus the generic names tirzepatide and semaglutide. Each name was measured in Latin script and in local scripts (for example マンジャロ, 마운자로, оземпик, مونجارو), and the scripts were added up.
- No double counting: Google groups close spellings into one number; each group was counted once.
- Countries: 90 countries with at least 1,000 brand searches a month.
- Limits: Keyword Planner rounds volumes into ranges. Searches show interest, not prescriptions or sales. Only Google is counted.
Bluedose is a personal shot log, not medical advice. Talk to your prescriber about which medicine is right for you.
Use this data
You can use these numbers and tables in articles, posts or research under CC BY 4.0. Please credit Bluedose with a link to this page.
Download the full dataset (CSV, 90 countries)
Also archived on Zenodo with a DOI for academic citation: doi.org/10.5281/zenodo.24406001
Credit line to copy:
<a href="https://bluedoseapp.com/data/glp-1-searches-by-country/">Bluedose GLP-1 search data</a>On Mounjaro, Ozempic or Wegovy?
Bluedose logs every shot, rotates injection sites and reminds you on shot day. Private, no account.
Free on the App Store